Company Overview of Clarus Ventures, LLC
Clarus Ventures, LLC is a venture capital and private equity firm specializing in investments in seed, start ups, early stage, mature, mid venture, late venture, growth capital, and PIPEs. It makes investments in life sciences sector with a focus on biopharmaceuticals, specialty pharma, medical device research equipments, biotechnology platforms or medical devices, and medical technology firms with products in development at value inflection points in their lifecycle. The firm targets investments in companies based in the United States and Europe. It makes investments between $15 million and $60 million per company. Clarus Ventures was founded in 2005 and is headquartered in Cambridge, Massa...
101 Main Street
Cambridge, MA 02142
Founded in 2005
Key Executives for Clarus Ventures, LLC
Co-Founder and Managing Director
Compensation as of Fiscal Year 2016.
Clarus Ventures, LLC Key Developments
Clarus Ventures, LLC Presents at Boston CEO Conference, May-31-2016 09:10 AM
May 24 16
Clarus Ventures, LLC Presents at Boston CEO Conference, May-31-2016 09:10 AM. Venue: Four Seasons Boston, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Kiran Reddy.
Clarus Ventures, LLC Presents at 1st Annual Neuroscience BioPartnering & Investment Forum, Feb-23-2016 11:05 AM
Jan 29 16
Clarus Ventures, LLC Presents at 1st Annual Neuroscience BioPartnering & Investment Forum, Feb-23-2016 11:05 AM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY 10007, United States. Speakers: Kiran Reddy, Venture Partner.
Clarus Ventures, LLC Announces Management Appointments
Jan 7 16
Clarus Ventures, LLC announced that appointments of Kiran Reddy, M.D., MBA, and Robert DeBenedetto, CPA, to Venture Partner, and Lazar Dimitrov, Ph.D., to Associate. Dr. Reddy will be based in the firm's Cambridge, Mass., office, and Dr. Dimitrov and Mr. DeBenedetto will be based in Clarus' South San Francisco, Calif., office. Dr. Reddy joins Clarus from Biogen's Corporate Strategy team where he focused on strategic transactions. As a Venture Partner at Clarus, Dr. Reddy will focus on both new company formation and risk-sharing partnerships with pharmaceutical companies. Robert DeBenedetto is currently CEO of SFJ Pharmaceuticals. Lazar Dimitrov joins Clarus from Blue Matter Consulting, where he advised clients on their immuno-oncology strategies.
Similar Private Companies By Industry
Recent Private Companies Transactions